NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $1.5 million, versus $2.9 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens Amid Favourable Trends
- UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
